FINMASON, INC. – Trademark Portfolio
Entity Type: 03
FINMASON, INC. holds 12 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 10 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 3 Nice Classification classes. Currently, 6 trademarks are registered. Notable registered marks include FINMASON, FINRIVER, THE ALGONATH, and THE FIVE-MINUTE FINANCIAL PLAN. The owner is based in Boston, MA.
One Marina Park Drive, Suite 1410
Boston, MA 02210
Showing of trademarks Trademarks
Trademark Classifications
FINMASON, INC.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Advertising; business management; business administration; office functions
Insurance; financial affairs; monetary affairs; real estate affairs
Frequently Asked Questions
How many trademarks does FINMASON, INC. have?
FINMASON, INC. has 12 U.S. trademarks filed with the USPTO. Of these, 6 registered, 3 abandoned, 3 cancelled.
What trademark classes does FINMASON, INC. file in?
FINMASON, INC. files trademarks across 3 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 35 (Advertising & Business), Class 36 (Insurance & Financial). Class 42 covers scientific and technological services; industrial analysis and research services.
What are FINMASON, INC.'s most well-known trademarks?
FINMASON, INC.'s registered trademark portfolio includes well-known marks such as FINMASON, FINRIVER, THE ALGONATH, and THE FIVE-MINUTE FINANCIAL PLAN. These are among 6 currently registered trademarks in the portfolio.
What is FINMASON, INC.'s trademark registration success rate?
FINMASON, INC. has a 50% trademark registration rate, with 6 out of 12 resolved applications resulting in successful registration. Currently, 0 applications are pending review.